Administration Panel stories:
UBS analyst boosts Amgen price target
Oct 12th, 2009 - The Seattle Times
A UBS analyst on Monday boosted his price target on Amgen Inc., saying the launch of the company's osteoporosis drug denosumab should drive the stock's value. UBS analyst...
FDA panel votes to eliminate Vicodin, Percocet
Jun 30th, 2009 - MSNBC
ADELPHI, Md. - Government experts say prescription drugs like Vicodin and Percocet that combine a popular painkiller with stronger narcotics should be eliminated because of their role in deadly overdoses.



